AccuBoost touts results of Accelerated Partial Breast Irradiation (APBI) trial
Advanced Radiation Therapy, creators of the AccuBoost Breast Brachytherapy technology, is pleased to embrace the results reported from an IRB approved prospective Phase II trial presented at the 2014 American Brachytherapy Society annual meeting. Dr. Jarek Hepel of Rhode Island Hospital reported on the results from this Non-Invasive Breast Brachytherapy (NIBB) APBI study sponsored by Brown University Oncology Research Group using a 34Gy, 10 fraction protocol. In summary, Dr. Hepel reported substantially less frequent and less severe toxicity to the skin and subcutaneous tissues.
Piran Sioshansi, President and CEO of Advanced Radiation Therapy commented, “We are very pleased with these initial results as they are consistent with both our expectations and with the results of the historical use of the technology for boost treatments.”